MEDIZEN HUMANCARE Inc. (XKON:236340)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,700.00
+30.00 (1.80%)
At close: Aug 22, 2025, 3:30 PM KST
1.80%
Market Cap3.92B
Revenue (ttm)583.88M
Net Income (ttm)-1.69B
Shares Out2.30M
EPS (ttm)-821.00
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume112
Average Volume300
Open1,700.00
Previous Close1,670.00
Day's Range1,670.00 - 1,700.00
52-Week Range1,432.00 - 4,100.00
Beta0.06
RSI39.35
Earnings Daten/a

About MEDIZEN HUMANCARE

MEDIZEN HUMANCARE Inc., a research company, engages in the genomic analysis to predict diseases on an individual basis in Asia, the Americas, Europe, and internationally. Its services include M-CHECK, which provides an analysis of patients’ risk for genetic diseases using genomic variation packages related to specific diseases with gene chips or analysis kits; and MELTHY (DTC), a DNA analysis service. The company was founded in 2012 and is based in Seoul, South Korea. [Read more]

Industry Commercial Physical and Biological Research
Founded 2012
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 236340
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.